EIF4E and diffuse large B-cell lymphoma: Our results agree with recent findings that the 4EBP/eIF4E ratio is a crucial determinant of asTORi sensitivity in cancer cells [15], [16], and extend this model to a naturally occurring DLBCL line deficient in 4EBP1.